Poland· PL-100162691
Cachexan
A megestrol product containing megestroli acetas, registered in Poland by Polfarmex S.A.. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Megestrol is registered in 11 of 19 countries.
Countries holding a registration under ATC L02AB01 (megestrol), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 7 of them publish a price we can compare per daily dose
Megestrol · ATC L02AB01
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- United Statesprice
Price per daily dose
What a daily dose of megestrol costs, country by country.
Normalised to the WHO defined daily dose (0.16 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Megestrol · price per daily dose (0.16 g)
USD · FX 28 Sept 2026
- IT Italy$2.30
The record
At a glance
URPL (Poland)- Active substance
- Megestroli acetas
- Manufacturer
- Polfarmex S.A.
- Country
- Poland (PL)
- ATC code
- L02AB01
- ATC class
- Megestrol
- Defined daily dose
- 0.16 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
1 priced- gtin05909990614608240 mlPLN 144.99
- gtin05909990614615
- gtin05909990614592
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
152 interactions on record for megestrol.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Megestrol · interactions on record
152 records
- 2 severe
- 147 moderate
- 3 minor
Most severe, free to view
- DofetilideC01BD04severe
- ThalidomideL04AX02severe
- AprepitantA04AD12moderate
- LiraglutidA08AX02moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Megestrol in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesMegestrol AcetatePreferred Pharmaceuticals Inc.
- IrelandMegace 40 mg/ml oral suspensionOriginalis B.V.
- SpainMAYGACE ALTAS DOSIS 40 mg/ml SUSPENSION ORALBausch Health Ireland Limited
- CzechiaMEGACEBausch Health Ireland Limited, Dublin
- United KingdomMegace 160mg tabletsDowelhurst Ltd
- ItalyGESTROLTEXISTITUTO GENTILI S.R.L.
- FinlandMegaceBristol-Myers Squibb Ab
- CanadaMEGESTROLAA PHARMA INC
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Belgium · Megace
- Cyprus · Megace
- Czechia · Megace, Megaplex
- Germany · Megestat
- Spain · Borea, Maygace Altas Dosis
- France · Megace
- United Kingdom (Northern Ireland) · Megace
- Greece · Megace
- Croatia · Megace, Megostat
- Hungary · Cachexi, Megace
- Ireland · Megace
- Italy · Gestroltex, Megace
- Lithuania · Megace
- Luxembourg · Megace
- Netherlands · Megestrolacetaat Focus
- Norway · Megace
- Portugal · Megace, Megestrol Generis
- Romania · Megesin
- Sweden · Megace
- Slovenia · Megace
- Slovakia · Megesin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d0015fde-c173-43ff-aeb8-796afcaeeea3 GET /v1/drugs/d0015fde-c173-43ff-aeb8-796afcaeeea3?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Zawiesina doustna",
"source": "urpl",
"strength": "40 mg/ml",
"packaging": "05909990614608 ¦ Rp ¦ 33429\n1 butelka 240 ml\n05909990614615 ¦ Rp ¦ Skasowane ¦ 33430\n1 op. 480 ml\n05909990614592 ¦ Rp ¦ Skasowane ¦ 67903\n1 op. 120 ml",
"substance": "Megestroli acetas",
"common_name": "Megestroli acetas",
"pl_product_id": "100162691",
"pozwolenie_nr": "12315",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about megestrol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.